AstraZeneca Annual Report and Financial Statements Form 20-F Information 2004 85 8 Segment information The Groups activities are in one class of business, pharmaceuticals.
There are no other significant classes of business, either singularly or in aggregate.
Geographic areas The tables below show information by geographic area and, for turnover and tangible fixed assets, material countries.
The figures show the turnover, operating profit and profit on ordinary activities before interest and taxation made by companies located in that area country, together with net operating assets and tangible fixed assets owned by the same companies: export sales and the related profit are included in the area country from which those sales were made.
In the US, sales to three wholesalers accounted for approximately 80% of our US sales.
AstraZeneca Annual Report and Financial Statements 86 Form 20-F Information 2004 Notes to the Financial Statements continued 8 Segment information continued Profit on ordinary Operating profit activities before after exceptional items interest and taxation 2004 2003 2002 2004 2003 2002 Profit from $m $m $m $m $m $m UK 1,074 810 672 1,076 812 673 Continental Europe 2,229 2,241 1,689 2,452 2,241 1,689 The Americas 1,192 816 1,473 1,192 816 1,473 Asia, Africa & Australasia 275 244 172 275 244 172 Continuing operations 4,770 4,111 4,006 4,995 4,113 4,007 Net operating assets 2004 2003 2002 $m $m $m UK 4,429 4,146 3,101 Continental Europe 5,483 5,771 4,805 The Americas 2,336 1,931 1,004 Asia, Africa & Australasia 1,194 1,033 958 Continuing operations 13,442 12,881 9,868 Net operating assets exclude short term investments, cash, short term borrowings, loans and non-operating debtors and creditors.
Tangible fixed assets 2004 2003 2002 $m $m $m UK 2,655 2,502 2,319 Sweden 2,359 2,122 1,626 US 1,153 1,095 1,031 Others 1,916 1,817 1,621 Continuing operations 8,083 7,536 6,597 Geographic markets The table below shows turnover in each geographic market in which customers are located.
